⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Methylphenidate for Cancer-Related Fatigue

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Methylphenidate for Cancer-Related Fatigue

Official Title: Methylphenidate for Cancer-Related Fatigue: A Pilot N-of-1 Study

Study ID: NCT01164956

Conditions

Cancer

Study Description

Brief Summary: The overall aim of this pilot study is to conduct a combined N-of-1 trial (N-1-T) of MPH (methylphenidate) for amelioration of fatigue in children with cancer, and to evaluate the N-1-T design both for individual clinical decision making and for clinical trials in symptom management in pediatric oncology patients. Because no one knows which of the study options are best, participants will receive liquid MPH on some days and a placebo on other days. We will compare how the participant feels on MPH days with how they feel on placebo days to determine whether MPH makes a difference.

Detailed Description: I. To assess the N-1-T as a study design to evaluate a symptom-directed intervention in children with cancer Primary objective -To evaluate the feasibility of conducting an N-1-T to evaluate MPH for cancer-related fatigue in children as a group Secondary objectives * To evaluate the ability of the N-1-T to assess efficacy of MPH for an individual subject statistically and clinically definite answer (regarding the ability of MPH to reduce fatigue) * To explore subject/family and oncologist perspectives on N1T participation * To examine in a preliminary fashion whether there are patient, family, disease or study-related factors that are associated with attrition to help guide future large-scale N1Ts II. To evaluate MPH for treatment of cancer-related fatigue and related symptoms in children Primary objective -To evaluate the effect of MPH on cancer-related fatigue in children based on various assessments including pedsFACIT-F and a unidimensional single-item Likert scale for measuring fatigue Secondary objective -To assess the side effect profile of MPH for fatigue in children with cancer III. To evaluate fatigue assessment tools Primary objective -To evaluate correlation between fatigue scores

Eligibility

Minimum Age: 7 Years

Eligible Ages: CHILD, ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Boston Children's Hospital, Boston, Massachusetts, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Contact Details

Name: Christina Ullrich, MD, MPH

Affiliation: Dana-Farber Cancer Institute/Children's Hospital Boston

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: